Rapport Therapeutics, Inc. Common Stock (RAPP) — QMA analysis
Sector: Healthcare · Market cap: $988M · Price: $25,93 · Data as of 2026-10-23
Rapport Therapeutics, Inc. Common Stock has a below-average composite score of 44/100, higher score than 50% of 22,734 tracked stocks. The highest-scoring layer is Analysts / transcripts; the lowest is Catalysts.
What 11 data layers say about RAPP
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 39/100 |
| Technical trend (TSS) | 48/100 |
| Relative strength (RS) | 29/100 |
| Momentum (USS) | 36/100 |
| Insider activity (IAS) | 57/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 55/100 |
| Institutional 13F (IFS) | 65/100 |
| Options flow (OFS) | 68/100 |
| News sentiment (NSS) | 57/100 |
| Analysts / transcripts (ATS) | 89/100 |
| Catalysts (XS) | 19/100 |
What does the QMA model currently show for Rapport Therapeutics, Inc. Common Stock?
The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.
For RAPP the layers diverge — some score high (Analysts / transcripts), others low (Catalysts). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
RAPP insider & smart money activity
Over the recent period we record 7 reported insider purchases and 22 sales for RAPP: predominance of reported sales (by dollar value). A description of the data layer, not an instruction.
How RAPP compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for RAPP stock?
44/100 (D) — Data as of 2026-10-23.
Are insiders buying RAPP stock?
Over the recent period, reported: purchases 7, sales 22 (purchases $1.66M, sales $7.02M). Insider activity: predominance of reported sales (by dollar value) — a description of reported data, not a trade instruction.
Where can I see live RAPP data?
Live RAPP data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]